Loading viewer...
earnings
Format: PDF earnings
UCB presented its full-year 2016 financial results on February 23, 2017, outlining its patient-focused innovation strategy and sustainable growth across its biopharmaceutical portfolio. The presentation highlights UCB's commitment to delivering differentiated solutions in therapeutic areas including epilepsy and rheumatoid arthritis through a networked, cross-functional approach.
earnings
42 Pages
Worldline
Tractor Supply Company Q3 2022 Financial Presentation
earningsearnings
10 Pages
Tractor Supply Company